简体中文
繁體中文
English
Pусский
日本語
ภาษาไทย
Tiếng Việt
Bahasa Indonesia
Español
हिन्दी
Filippiiniläinen
Français
Deutsch
Português
Türkçe
한국어
العربية
Silver Smashes $70: Is the "Forced Central Bank Buying" Thesis Playing Out?
Abstract:Spot Silver (XAG/USD) has aggressively breached the psychological $70/oz barrier, trading as high as $72 this week. The surge validates a growing macro-thesis that silver is transitioning from a mere industrial metal to a critical monetary reserve asset.

XAG/USD | Commodities | Central Bank Reserves
Spot Silver (XAG/USD) has aggressively breached the psychological $70/oz barrier, trading as high as $72 this week. The surge validates a growing macro-thesis that silver is transitioning from a mere industrial metal to a critical monetary reserve asset.
The “No Choice” Buy
Clocktower Chief Strategist Kevin Wang has highlighted a structural shift driving this rally: the “Forced Buyer” hypothesis.
- Sovereign Debt Risks: With global debt exceeding $300 trillion and Western bond markets facing fiscal discipline questions, Central Banks are diversifying away from fiat-backed bonds.
- Gold is Crowded: With Gold (XAU/USD) already at inflation-adjusted highs, Central Banks seeking hard assets have limited alternatives. Platinum and Palladium markets are too thin to absorb sovereign-level capital flows.
- Silvers Role: This leaves Silver as the primary liquid alternative for de-dollarization flows.
Technical Drivers: The Gold-Silver Ratio
Market analysts note a critical technical breakdown in the Gold-Silver Ratio, which has fallen below a 15-year rising trend channel. Historically, this signal precedes a period of significant outperformance by Silver relative to Gold.
Furthermore, adjusted for inflation, Silver prices are only just breaking out of long-term downtrends, suggesting substantial catch-up potential compared to Gold's mature bull market. If the Federal Reserve is perceived to fall “behind the curve” on inflation in 2026, real rates could dip further, adding rocket fuel to the metal's ascent.
Disclaimer:
The views in this article only represent the author's personal views, and do not constitute investment advice on this platform. This platform does not guarantee the accuracy, completeness and timeliness of the information in the article, and will not be liable for any loss caused by the use of or reliance on the information in the article.
